health of the nervous system

Ataxia in brief: Summary on ataxia

Scroll down the page to read the summary table on ataxia.

Ataxia Consistent disorder in lack of muscle coordination, which makes it difficult to perform voluntary movements: ataxia causes progressive inability to move, often associated with muscle pain
General characteristics of ataxia
  • Movements of reduced or excessive width
  • Unsteady, uncertain and shaky gait
  • Simultaneous spasms and contraction of antagonistic muscle bundles
  • Injury in the cerebellum, spinal cord and peripheral nerves
Degeneration of ataxia Onset: few ataxic manifestations that progressively degenerate

Evolution: pronounced ataxia in the legs and arms

Degeneration: impairment of the voice and the articulation of speech, muscles, hearing and sight

Ataxia and ataxic syndromes
  1. Ataxic syndrome: set of invalidating genetic movement diseases
  2. Ataxia: cardinal symptom of ataxic syndromes
Ataxia: incidence index Italy: about 5, 000 people suffering from ataxia

4.5-6.4 subjects affected per 100, 000 healthy individuals

Ataxia and associated diseases Incontinence, swallowing difficulties, uncoordination and slowness of eye movements, other uncontrolled and involuntary movements of the head, trunk and lower / upper limbs, memory loss, cardiac disorders and bronchopulmonary complications
General classification of ataxia
  • Limb ataxia: diagnosed on the patient in a static position
  • Ataxic March: appears during movement
Classification of ataxia according to the affected anatomical site
  • Cerebellar ataxia
  • Brain ataxia
  • Sensitive ataxia
  • Labyrinthine ataxia
Hereditary and secondary ataxias
  1. Secondary ataxias: due to trauma, viral infections, drug or alcohol abuse, and repeated exposure to radiation.
  1. Hereditary ataxias:
  • Friedreich's ataxia
  • Spino-cerebellar ataxias
  • Telangiectatic ataxia
  • Sensitive ataxia
  • Charcot-Marie ataxia
  • Cerebellar atrophy
Classification of cerebellar ataxias based on age at onset
  • Ataxia-teleagectasia and Hypoxic-ischemic syndrome (generally, appear within the child's two years of age)
  • Autosomal-dominant cerebellar ataxia, Friedreich's ataxia (between 2 and 5 years of age)
  • Spino-cerebellar ataxia, typical of adolescents
Classification of cerebellar ataxias according to the triggering factors
  • Ataxia from neoplastic and preneoplastic causes
  • Ataxia from degenerative and neurodegenerative causes
  • Infection ataxia
  • Ataxia generated by metabolic deficits
  • Ataxia from drug intoxication
Genetic transmission of ataxia Autosomal dominant transmission: a parent is affected by dominant ataxia → transmission of the mutated gene to the child

Autosomal recessive transmission: healthy carriers of the disease → transmission of ataxia to the child

Ataxia: symptoms Onset manifestations depend on the severity of the ataxic pathology and, above all, on the triggering cause

Common factor in all ataxic forms: slow, progressive and unstoppable degeneration of ataxic symptoms

  1. Onset: uncoordinated movement of limbs, hands and feet
  2. Disease evolution: verbal modulations, increasingly unstable and uncertain patient gait, less controlled coordination of the limbs
  3. Degeneration: involvement of respiratory and swallowing muscles, serious cardiac complications and death
Ataxia: complications Ataxia: possible spy of neoplasms

Possible cardiac, respiratory, swallowing degeneration

Ataxia: causes Mutation of the genetic code of a gene: CNS alteration (attack on the cerebellum)

Ataxia: consequence of more or less serious pathologies: infections, drug intoxication, alcohol or chemical substances, multiple sclerosis and demyelinating diseases, neurovegetative pathologies, malignant neoplasms, emboli, sickle cell anemia, vascular problems in general and lesions in the dorsal columns

Ataxia: diagnosis The diagnosis of ataxia is mainly clinical and symptomatic. Diagnostic options:
  • Romberg maneuver
  • Molecular test
  • CT (computed tomography)
  • MRI (or MRI)
  • SPECT (Single Photon Emission Computed Tomography)
Ataxia: therapies and rehabilitation There is no effective pharmacological therapy in neurological-muscular type ataxias
  • Rehabilitation: objectives
    • Restoring motor alterations
    • Monitor pathological kinetic movements
    • Increase patient self-sufficiency and self-esteem
Therapeutic hypotheses to improve Friedreich's ataxia: administration of iron chelators and antioxidants
Friedreich's ataxia Description : the most famous degenerative movement disorder, a genetic anomaly with an autosomal-recessive transmission responsible for the progressive and inevitable damage to the central and peripheral nervous system

Incidence index

Approximately 100, 000 sick people from this ataxia, of which 1, 200 are Italian

Molecular genetics

Mutated gene responsible for the Frefreich ataxia: FXN or X25

Symptoms

Onset : the affected subject is unable to maintain a certain correct posture for long periods

Disease progression : disturbances in performing the simplest activities, such as eating, speaking, writing, etc.

Degeneration and complications : severe heart disease, scoliosis, hollow foot, increased heart rate, altered electrocardiogram and enlarged ventricular septum walls

Diagnosis and therapies

  • Molecular diagnosis (to identify the mutated gene)
  • MRI scan
  • Neurophysiological examinations
  • Lab test
  • Annual or semi-annual blood glucose monitoring
  • Administration of specific pharmacological specialties (in the case of heart problems)
Cerebellar ataxia Description : the cerebellar forms frame neurodegenerative disorders, responsible for the progressive motor uncoordination of the lower and upper limbs, involuntary ocular wave movements and difficulty in articulating the word

Classification :

  • Cerebellar ataxia with autosomal-dominant transmission: affects 0.8-3.5 subjects per 100, 000 healthy individuals. Rises around 30-50 years
  • Cerebellar ataxia with autosomal-recessive transmission: affects about 7 cases per 100, 000 healthy individuals. It starts around 20 years of age
Symptomatology :

Onset : walking and postural deficits, and with difficulty in coordinating joint movements

Evolution of the disease: damage to the eye (optic atrophy, nystagmus, pupil abnormalities, retinitis pigmentosa, ophthalmoplegia etc.)

Other symptoms: cerebellum hypoplasia, hyporeflexia, asthma, emphysema, muscle spasticity, diabetes, speech deficit and behavioral disorders

Causes :

The causes of transmission of cerebellar ataxia lie in genetics and gene mutation

Hypothetically related diseases:

Vitamin E deficiency, hypogonadotropic hypogonadism, celiac disease, neoplasms, inflammatory and vascular lesions affecting the cerebellum

Diagnosis:

  • Neurological examination
  • MRI scan
  • Blood analysis
  • Molecular tests
therapies:

Effective treatment has not yet been identified. Important palliative therapies (eg physiotherapy)

Charcot-Marie-Tooth Ataxia Description : it is one of the family neurological hereditary diseases: first the syndrome affects the nerves, then, by induction, it also damages the muscles and the other sites of the body

Incidence : a rather rare disease, which however represents the most widespread inherited neurological ataxia. Afflicts 36 cases per 100, 000 healthy

Terminology and synonyms:

  • CM (Charcot-Marie),
  • HMSN (Hereditary Motor and Sensory Neuropathie),
  • PMA (Peroneal or Progressive Muscolar Atrophy)
  • Hereditary motor-sensory neuropathy
symptoms:
  • Tactile hypersensitivity and loss of leg muscle tone (type 1A Charcot-Marie-Tooth ataxia)
  • Slow but progressive and unstoppable degeneration of the disease
  • Less frequent symptoms: claw-like hands and general hand deformity, tendon shortening, loss of balance, motor uncoordination, areflexia (lack of reflexes), osteo-muscular pains, nerve impairment and muscle atrophy
Classification:

Given the heterogeneity of disorders derived from the disease, the ataxic forms of Charcot-Marie-Tooth have been classified into five large groups, in turn differentiated into other sub-categories

Diagnosis and therapies

The diagnosis highlights:

  • Symmetrical muscular atrophy involving the muscles of the foot, fibula and common extensor of the fingers
  • Paralysis of feet and hands
  • Schwann cell hyperplasia
  • Alteration of myelin sheaths
  • Thickened connective tissue
There is also no definitive cure in the Charcot-Marie-Tooth ataxia.